iBio
IBIO
$1.76
Share price
2.33%
Change (1 day)
62.96%
Change (1 year)
Categories
Market capitalization of iBio (IBIO)
Market cap: $15.15 Million
As of April 2024 iBio has a market cap of $15.15 Million. This makes iBio the world's 8057th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of iBio from 2008 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $15.15 M | 451.75% |
| 2023 | $2.74 M | -31.34% |
| 2022 | $4 M | -96.66% |
| 2021 | $0.11 B | -46.19% |
| 2020 | $0.22 B | 1536.51% |
| 2019 | $13.58 M | -4.26% |
| 2018 | $14.19 M | -30.51% |
| 2017 | $20.42 M | -41.98% |
| 2016 | $35.19 M | -18.72% |
| 2015 | $43.3 M | -12.18% |
| 2014 | $49.3 M | 128.4% |
| 2013 | $21.58 M | -27.11% |
| 2012 | $29.61 M | 10.19% |
| 2011 | $26.87 M | -73.66% |
| 2010 | $0.10 B | 301.03% |
| 2009 | $25.44 M | 933.09% |
| 2008 | $2.46 M |
End of Day market cap according to different sources
On Apr 28th, 2024 the market cap of iBio was reported to be:
$15.15 Million
$15.15 Million
$6.13 Million
$6.13 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $352.16 B | 2,323,479.45% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | $0 M | -99.96% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.24 B | 1,499.19% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.10 B | 563.69% | 🇺🇸 USA |